CIK 0001429260 · Non-accelerated filer<br>Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205157386
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-01 | Rowinsky Eric K Director | Grant or award | +6,666 | 68,797 | ||
| 2024-01-01 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Grant or award | +216,465 | 2,813,905 | ||
| 2023-12-20 | Jin David Chief Financial Officer | Grant or award | +140,000 | 235,916 | ||
| 2023-11-14 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +1,567,515 | $1.70 | $2.7M | 2,597,440 |
| 2023-11-14 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase · Warrants to purchase Common Stock | +1,567,515 | 1,567,515 | ||
| 2023-11-14 | WEISS MICHAEL S See Remarks | Purchase | +147,058 | $1.70 | $250K | 1,130,520 |
| 2023-11-14 | WEISS MICHAEL S See Remarks | Purchase · Warrants to purchase Common Stock | +147,058 | 147,058 | ||
| 2023-09-26 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +100,000 | $0.28 | $28K | 15,449,091 |
| 2023-08-18 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +10,000 | $9.34 | $93K | 112,500 |
| 2023-08-17 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +10,000 | $11.75 | $118K | 102,500 |
| 2023-02-10 | WEISS MICHAEL S See Remarks | Purchase | +1,197,604 | $0.84 | $1000K | 14,752,034 |
| 2023-02-10 | Rowinsky Eric K Director | Purchase | +11,976 | $0.84 | $10K | 931,976 |
| 2023-02-10 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Purchase | +2,395,209 | $0.84 | $2.0M | 15,349,091 |
| 2023-02-10 | Lu Lucy Director | Purchase | +11,976 | $0.84 | $10K | 133,379 |
| 2023-02-10 | LOBELL J JAY Director | Purchase | +299,401 | $0.84 | $250K | 1,635,401 |
| 2023-02-10 | Jin David Chief Financial Officer | Purchase | +35,928 | $0.84 | $30K | 1,438,757 |
| 2023-01-01 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Grant or award | +1,219,294 | 12,953,882 | ||
| 2023-01-01 | Lu Lucy Director | Grant or award | +50,000 | 121,403 | ||
| 2023-01-01 | WEISS MICHAEL S See Remarks | Grant or award | +1,219,294 | 13,554,430 | ||
| 2023-01-01 | Rowinsky Eric K Director | Grant or award | +100,000 | 920,000 |
Page 3 of 6 · 105 trades